| Nov 7 |
Compared to Estimates, Haemonetics (HAE) Q2 Earnings: A Look at Key Metrics
|
| Nov 7 |
Haemonetics (HAE) Tops Q2 Earnings and Revenue Estimates
|
| Nov 7 |
Haemonetics: Fiscal Q2 Earnings Snapshot
|
| Nov 7 |
Haemonetics Non-GAAP EPS of $1.12 beats by $0.05, revenue of $346M beats by $3.42M
|
| Nov 7 |
Haemonetics 2nd Quarter Fiscal Year 2025 Earnings Release Available on Investor Relations Website
|
| Nov 6 |
Haemonetics Q2 2025 Earnings Preview
|
| Nov 6 |
Haemonetics (HAE) Q2 Earnings on the Horizon: Analysts' Insights on Key Performance Measures
|
| Nov 6 |
Solventum Q3 Earnings Likely to Reflect Declining Volume Trend
|
| Oct 31 |
Haemonetics (HAE) Earnings Expected to Grow: Should You Buy?
|
| Oct 29 |
Here's Why You Should Retain ABT Stock in Your Portfolio Now
|
